The production of tumour necrosis factor-alpha is decreased in peripheral blood mononuclear cells from multidrug-resistant tuberculosis patients following stimulation with the 30-kDa antigen of Mycobacterium tuberculosis
Open Access
- 29 May 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 132 (3) , 443-449
- https://doi.org/10.1046/j.1365-2249.2003.02172.x
Abstract
The clearance of intracellular bacteria requires the appropriate induction of proinflammatory cytokines and chemokines to recruit macrophages and T cells to the site of infection. In this study, we investigated the production of tumour necrosis factor (TNF)‐α, interleukin (IL)‐8 and interferon (IFN)‐γ by the peripheral blood mononuclear cells (PBMC) of patients with multidrug‐resistant tuberculosis (MDR‐TB) in response to in vitro stimulation with the 30‐kDa antigen of Mycobacterium tuberculosis. The results were compared with those from cases of newly diagnosed TB (N‐TB) and TB with treatment failure (TF‐TB), and healthy tuberculin reactors (HTR). The most significantly depressed TNF‐α levels were found in MDR‐TB patients. IFN‐γ production was depressed significantly in all groups of TB patients compared with the HTR group. TNF‐α secretion in response to the 30‐kDa antigen was unchanged by coculturing with recombinant human interferon (rhIFN)‐γ, and was increased dramatically following IL‐10 neutralization with an anti‐human IL‐10 antibody. The IL‐8 levels were depressed significantly in MDR‐TB patients compared with N‐TB patients, but were similar to the IL‐8 levels in TF‐TB patients. Furthermore, rhTNF‐α directly increased IL‐8 secretion, and neutralizing antibody to TNF‐α inhibited IL‐8 production by the PBMC of MDR‐TB patients that were stimulated with the 30‐kDa antigen. Taken together, these data suggest that the PBMC of MDR‐TB patients typically show TNF‐α depression in response to the 30‐kDa antigen, and this effect is modulated by IL‐10. In addition, we highlight the role of TNF‐α in IL‐8 secretion in MDR‐TB patients.Keywords
This publication has 36 references indexed in Scilit:
- Comparative and Prospective Study of Different Immune Parameters in Healthy Subjects at Risk for Tuberculosis and in Tuberculosis PatientsClinical and Vaccine Immunology, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Down-Regulation of Interleukin-8 Secretion fromMycobacterium tuberculosis-Infected Monocytes by Interleukin-4 and -10 but Not by Interleukin-13Infection and Immunity, 2001
- Depressed Interleukin-12 (IL-12), but not IL-18, Production in Response to a 30- or 32-Kilodalton Mycobacterial Antigen in Patients with Active Pulmonary TuberculosisInfection and Immunity, 2000
- Dysregulated Production of Interferon-gamma, Interleukin-4 and Interleukin-6 in Early Tuberculosis Patients in Response to Antigen 85B of Mycobacterium tuberculosisScandinavian Journal of Immunology, 2000
- Analysis of the local kinetics and localization of interleukin‐1α, tumour necrosis‘qc factor‐α and transforming growth factor‐β, during the course of experimental pulmonary tuberculosisImmunology, 1997
- Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in miceImmunity, 1995
- Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infectionClinical and Experimental Immunology, 1995
- Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components.Journal of Clinical Investigation, 1995
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991